July 14, 2026 — New research is shedding new light on the biological basis of schizophrenia by directly measuring synaptic connections in the human brain using specialized positron emission tomography (PET) imaging.

July 14, 2026 — A team of crew members aboard a commercial spaceflight acquired the first diagnostic X-rays during an orbital flight. Results of the mission were published recently in Radiology, a journal of the Radiological Society of North America (RSNA).

July 13, 2026 — Neal F. Kassell, MD, founder and chairman of the Focused Ultrasound Foundation, received the inaugural Lifetime Impact Award at the 2026 annual meeting of the International Society for Therapeutic Ultrasound (ISTU) in Norway in June. The award honors individuals whose work has fundamentally shaped the development, adoption and global impact of focused ultrasound.

July 10, 2026 — A new study led by researchers at the Icahn School of Medicine at Mount Sinai found that although the overall number of radiation oncology clinics in the United States has appeared stable in recent years, many individual treatment centers have quietly closed while others have opened. The closures have disproportionately affected rural and freestanding practices, reducing access to lifesaving radiation therapy for patients to receive lifesaving cancer treatment close to home.

July 9, 2026 — Viz.ai has announced a collaboration with Cortechs.ai to integrate Cortechs.ai's NeuroQuant and NeuroQuant MS suite into the Viz.ai platform, expanding access to quantitative neuroimaging for hospitals and health systems across the U.S. This partnership marks Viz.ai's expansion into neurodegenerative disease, growing Viz Neuro Suite beyond its neuro offerings.

July 8, 2026 — Freeland Systems, a cloud PACS and clinical imaging software company, has launched its new customer dashboard, a portal built specifically for AccessPoint PACS users. The dashboard brings system status, documentation, video training and support resources into a single screen, reflecting Freeland Systems' shift toward more proactive customer support.

July 7, 2026 — Longeviti Neuro Solutions has launched a new strategic initiative, ClearFit AI, a Brain Ultrasound Interface (BUI). This new technology create a persistent acoustic interface to the brain, enabling real-time bedside imaging and supporting future advances in neurosurgical care.

The ClearFit AI platform combines:

  • ClearFit sonolucent cranial implants

July 8, 2026 — GE HealthCare and Mayo Clinic have announced the MI-BET (Molecular Imaging Biomarker-Based End of Therapy Trial) research collaboration, a novel theranostics study designed to explore a more personalized approach to radioligand therapy (RLT) for patients with advanced prostate cancer.

July 8,2026 — CorePlus, Puerto Rico’s fully digital precision pathology and clinical laboratory, has announced the integration of the ArteraAI Prostate Test into its diagnostic workflows. It is the first laboratory in Puerto Rico to bring this guideline-recommended AI test into routine clinical use, allowing for fast and convenient delivery of treatment insights. The ArteraAI Prostate Test is an advanced risk stratification tool to help personalize and optimize treatments for patients with localized prostate cancer.

Subscribe to
© Copyright Wainscot Media. All Rights Reserved.
Subscribe Now